ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

ClinicalTrials.gov ID: NCT06260722

Public ClinicalTrials.gov record NCT06260722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 3:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Semaglutide Once Weekly in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

Study identification

NCT ID
NCT06260722
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,250 participants

Conditions and interventions

Interventions

  • Retatrutide Drug
  • Semaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 20, 2024
Primary completion
Jul 31, 2026
Completion
Dec 31, 2026
Last update posted
Apr 12, 2026

2024 – 2027

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
University of Alabama - Department of Nutrition Sciences Birmingham Alabama 35294
Neighborhood Healthcare Institute of Health Escondido California 92025
Long Beach Research Institute Long Beach California 90805
Valley Clinical Trials, Inc. Northridge California 91325
Rancho Cucamonga Clinical Research Rancho Cucamonga California 91730
University of Colorado Anschutz Medical Campus Aurora Colorado 80045
Arrow Clinical Trials Daytona Beach Florida 32117
New Age Medical Research Corporation Miami Florida 33186
South Broward Research Miramar Florida 33027
Clinical Research of Central Florida Winter Haven Florida 33880
Herman Clinical Research Suwanee Georgia 30024
North Georgia Clinical Research Woodstock Georgia 30189
Pacific Diabetes & Endocrine Center Honolulu Hawaii 96817
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Deaconess Clinic - Gateway Health Center Newburgh Indiana 47630
IMA Clinical Research Monroe - Armand Monroe Louisiana 71201
MedStar Health Research Institute (MedStar Physician Based Research Network) Hyattsville Maryland 20782
Brigham and Women's Hospital Diabetes Program Boston Massachusetts 02115
NECCR PrimaCare Research Fall River Massachusetts 02721
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098
Palm Research Center Tenaya Las Vegas Nevada 89128
Palm Research Center Sunset Las Vegas Nevada 89148
NYC Research INC Long Island City New York 11106
Medication Management Greensboro North Carolina 27405
Remington Davis Clinical Research Columbus Ohio 43215
Alliance for Multispecialty Research, LLC Norman Oklahoma 73069
Central States Research Tulsa Oklahoma 74136
The Corvallis Clinic, P.C. Corvallis Oregon 97330
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Velocity Clinical Research, Dallas Dallas Texas 75230
Valley Institute of Research - Fort Worth Fort Worth Texas 76164
Juno Research Houston Texas 77040
Southern Endocrinology Associates Mesquite Texas 75149
Consano Clinical Research, LLC Shavano Park Texas 78231
Texas Valley Clinical Research Weslaco Texas 78596
Medrasa Clinical Research Wylie Texas 75098
Central Washington Health Services Association d/b/a Confluence Health Wenatchee Washington 98801
IMA Clinical Research West Virginia Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06260722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06260722 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →